(Total Views: 439)
Posted On: 06/13/2018 5:53:02 AM
Post# of 72446
For those that making claims that Leo should have pursued Phase III for B ABSSSI, see the FDA statement below and you will see why IPIX smartly elected to determine the B-OM and B-UP capabilities first.
https://www.fda.gov/NewsEvents/Newsroom/Press...rce=Eloqua
https://www.fda.gov/NewsEvents/Newsroom/Press...rce=Eloqua
(4)
(0)
